[
  {
    "instruction": "Analyze the molecule CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(c1ccc(Oc2ccc3c(c2)C(=O)OC3=O)cc1)c1ccc(Oc2ccc3c(c2)C(=O)OC3=O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 6 rings containing 4 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(C(C)(C)C)c(O)c(C)c1Cn1c(=O)n(Cc2c(C)cc(C(C)(C)C)c(O)c2C)c(=O)n(Cc2c(C)cc(C(C)(C)C)c(O)c2C)c1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 4 rings containing 4 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1nnc(-c2ccccc2)c(=O)n1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule N=C(N)NCC1COc2ccccc2O1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cccc(C)c1NC(=O)NC1=CCCN1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule c1csc(C2(N3CCCCC3)CCCCC2)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(Cl)cc1C(=O)NCCc1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC12CC1(C)C(=O)N(c1cc(Cl)cc(Cl)c1)C2=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N#Cc1ccc(C(c2ccc(C#N)cc2)n2cncn2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). The presence of these structural features suggests potential for nuclear receptor activation (NR-Aromatase) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 5 rings containing 3 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR, NR-AhR) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)CCOC1=Cc2ccccc2Sc2ccc(Cl)cc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(OC)nc(NC(=O)NS(=O)(=O)c2ncccc2C(=O)N(C)C)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC1=CC(=O)OC(CCc2ccccc2)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@@H](Cc1ccccc1)NCCC(c1ccccc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCc1ncc(C[n+]2ccccc2C)c(N)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[N+]1(CCCCC[N+]2(C)CCCC2)CCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)CCC(=Cc2ccc(Cl)cc2)C1(O)Cn1cncn1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for nuclear receptor activation (NR-AR, NR-AhR) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(Nc1ccccc1)Nc1cnns1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule [O-][n+]1ccccc1[S][Zn][S]c1cccc[n+]1[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR-LBD, NR-ER-LBD, NR-PPAR-gamma) and cellular stress response (SR-ATAD5, SR-HSE, SR-MMP, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 4 rings containing 4 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR, NR-Aromatase) and cellular stress response (SR-ARE, SR-HSE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic polycyclic system with 5 rings containing 3 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-HSE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule [Cl][Zr]([Cl])([C]1=CC=CC1)[CH]1C=CC=C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)COCC(CN(Cc1ccccc1)c1ccccc1)N1CCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(CCC(=O)OCCOCCOCCOC(=O)CCc2cc(C)c(O)c(C(C)(C)C)c2)cc(C(C)(C)C)c1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CNS(=O)(=O)CCc1ccc2[nH]cc(C3CCN(C)CC3)c2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O[C@@H](CNC[C@H](O)[C@H]1CCc2cc(F)ccc2O1)[C@@H]1CCc2cc(F)ccc2O1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC[C@@H]([C@H](C)O)n1ncn(-c2ccc(N3CCN(c4ccc(OCC5CO[C@@](Cn6cncn6)(c6ccc(F)cc6F)C5)cc4)CC3)cc2)c1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic polycyclic system with 7 rings containing 5 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 4 rings containing 4 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR, NR-Aromatase) and cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(OC(=O)c1ccccc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(O)c2c3c4c(cc(O)c13)C(C)(C)C(=O)c1c(O)cc(O)c(c1-4)C2=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 5 rings containing 3 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The presence of these structural features suggests potential for cellular stress response (SR-MMP, SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(C(=O)OCCCN2CCCN(CCCOC(=O)c3cc(OC)c(OC)c(OC)c3)CC2)cc(OC)c1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCn1cc(C(=O)O)c(=O)c2cnc(N3CCCC3)nc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=c1[nH]c2ccccc2c(=O)o1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 2 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN1C(=CC=Cc2sc3ccccc3[n+]2CC)Sc2ccccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: aniline moiety. The presence of these structural features suggests potential for cellular stress response (SR-ARE, SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC/C=C1/OC(=O)c2ccccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)=C1CC[C@@H](C)CC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc2cc3c4ccccc4c4ccccc4c3cc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly lipophilic polycyclic system with 5 rings containing 5 aromatic ring(s). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-Aromatase) and cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=S(=O)(O)c1ccc(Nc2nc(Nc3ccc(/C=C/c4ccc(Nc5nc(Nc6ccc(S(=O)(=O)O)cc6)nc(N(CCO)CCO)n5)cc4S(=O)(=O)O)c(S(=O)(=O)O)c3)nc(N(CCO)CCO)n2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, moderately polar polycyclic system with 6 rings containing 6 aromatic ring(s). MODERATE-RISK: aniline moiety. these structural features indicate this compound may exhibit cellular stress response (SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@H]([N+]3(C)CCCCC3)[C@@H]4OC(C)=O)[C@@]2(C)C[C@@H]1[N+]1(C)CCCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 6 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)O[C@H]1C(=O)[C@@]2(C)[C@H]([C@H](OC(=O)c3ccccc3)[C@]3(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c4ccccc4)c4ccccc4)C(C)=C1C3(C)C)[C@]1(OC(C)=O)CO[C@@H]1C[C@@H]2O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity polycyclic system with 7 rings containing 3 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(CCCCCCCCCCCCC1CCCC1)Nc1ccc(S(=O)(=O)c2ccc(NC(=O)CCCCCCCCCCCCC3CCCC3)cc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCc1c2c(nc3ccc(OC(=O)N4CCC(N5CCCCC5)CC4)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic polycyclic system with 7 rings containing 3 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with cellular stress response (SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule NC[C@H]1O[C@H](O[C@H]2[C@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)C(O)[C@H](N)C[C@@H]2N)[C@H](N)[C@@H](O)[C@@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly hydrophilic polycyclic system with 3 rings. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(=O)NCCC1CCc2ccc3c(c21)CCO3 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC1(c2cccc(O)c2)CCCCN(C)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=Cc1c(C)c2cc3nc(c(CC(=O)O)c4[nH]c(cc5nc(cc1[nH]2)C(C)=C5CC)c(C)c4C(=O)O)C(CCC(=O)O)C3C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 5 rings containing 3 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCn1cc(C(=O)O)c(=O)c2ccc(C)nc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc2cc(Nc3ccc(Nc4ccc5ccccc5c4)cc3)ccc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic polycyclic system with 5 rings containing 5 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(C)c(C=C2C(=O)Nc3ccccc32)[nH]1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc(CN(CC2=NCCN2)c2ccccc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)Nc1ccc2c(c1)N(C(=O)CCN1CCOCC1)c1ccccc1S2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(N)c(Cl)cc1C(=O)NC1CCN(Cc2ccccc2)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1c(-c2ccccc2)oc2c(C(=O)OCCN3CCCCC3)cccc2c1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 3 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1CCC(CN2c3ccccc3Sc3ccccc32)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C/N=C/c1ccccc1O)/N=C/c1ccccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCOc1ccccc1/C(=C\\SC)n1ccnc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). these structural features indicate this compound may exhibit cellular stress response (SR-ARE, SR-HSE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc([N+](=O)[O-])[c]2c1[O][Hg]2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar bicyclic framework containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(=O)oc2cc(O[C@@H]3SC[C@@H](O)[C@H](O)[C@H]3O)ccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 2 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)Oc1cc(-n2nc(C(C)(C)C)oc2=O)c(Cl)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for cellular stress response (SR-ARE, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCN1CCCC1C(=O)Nc1c(C)cc(C)cc1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@H]1[C@@H](c2ccccc2)N=C(O)N1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)COc1ccc(CCNS(=O)(=O)c2ccccc2)s1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1ccc(NC2OC[C@@H](O)[C@H](O)[C@H]2O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cn1c(=N)[nH]c2[nH]cnc2c1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic bicyclic framework containing 2 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cnc(C2=NC(=O)C(C)(C(C)C)N2)c(C(=O)O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(OC)nc(Sc2cccc(Cl)c2C(=O)O)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 4 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for nuclear receptor activation (NR-PPAR-gamma) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(Oc1c(Cl)cccc1Cl)C1=NCCN1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC=C1CC2C=CC1C2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](OC(=O)c3ccccc3C(=O)O)[C@H](O)O[C@@H]2COC(C)=O)[C@H](O)[C@@H](OC(=O)c2ccccc2C(=O)O)[C@@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic polycyclic system with 4 rings containing 2 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(c1ccccc1)C1CCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CSC(=O)c1cccc2nnsc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc2c(OCC(CNC(C)(C)C)OC(=O)c3ccccc3)cccc2[nH]1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)Oc1ccc(C(c2ccc(OC(C)=O)cc2)c2ccccn2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit cellular stress response (SR-MMP, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(C(=O)Oc2ccc(C(O)CNC(C)(C)C)cc2OC(=O)c2ccc(C)cc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OC(CCN1CCCC1)(c1ccccc1)C1CCCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(C)nc(-n2nc(C)cc2OC)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccsc1C(=CCCN1CCC[C@@H](C(=O)O)C1)c1sccc1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCc1ncc(/C=C(\\Cc2cccs2)C(=O)O)n1Cc1ccc(C(=O)O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[N+]1(C)[C@@H]2CC(OC(=O)C(O)(c3cccs3)c3cccs3)C[C@H]1[C@@H]1O[C@@H]12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 5 rings containing 2 aromatic ring(s). HIGH-RISK FEATURES: epoxide ring (DNA alkylation risk). SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CO/N=C1/C[C@]2(C[C@@H]3C[C@@H](CC=C(C)C[C@@H](C)C=CC=C4CO[C@@H]5[C@H](O)C(C)=C[C@@H](C(=O)O3)[C@]45O)O2)O[C@H](/C(C)=C/C(C)C)[C@H]1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic polycyclic system with 5 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-AR, NR-AR-LBD) and cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule S=P(N1CC1)(N1CC1)N1CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar polycyclic system with 3 rings. Structural analysis reveals these structural features that correlate with cellular stress response (SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)CCN(Cc1ccsc1)c1ccccn1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1CCc2nccnc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O[C@H]1[C@H]2[C@H](O)CCCN2C[C@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic bicyclic framework. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O[C@@H]1C[C@@H]2C[C@@H]3C[C@H](C1)N2CC3=O)c1c[nH]c2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 6 rings containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=c1[nH]c(=O)c2[nH]c(=O)[nH]c2[nH]1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic bicyclic framework containing 2 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Fc1ccc(Oc2ccnc3cc(Cl)cc(Cl)c23)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-PPAR-gamma) and cellular stress response (SR-ARE, SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule OC(CCCN1CCCCC1)(c1ccccc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc(-c2ccc(-c3ccccc3)cc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-ATAD5) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)c1c(C(F)F)nc(C(F)(F)F)c(C2=NCCS2)c1CC(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 5 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc2c(c1)c1c3n2CCN(C)C3=NCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 4 rings containing 2 aromatic ring(s). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc(S(=O)(=O)Nc2ccccn2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)C2=CCCC(C)(C)[C@]23CC[C@H]1C3 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings. The presence of these structural features suggests potential for nuclear receptor activation (NR-Aromatase) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1nc2nc[nH]c2c(=S)[nH]1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-Aromatase, NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE, SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCn1cc(C(=O)O)c(=O)c2cnc(N3CCNCC3)nc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@H](N3CC[N+](C)(C)CC3)[C@@H]4OC(C)=O)[C@@]2(C)C[C@@H]1N1CC[N+](C)(C)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity polycyclic system with 6 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1ccccc1C(=O)Nc1ccc(S(=O)(=O)Nc2nccs2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=c1[nH]c2ccccc2n1C1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 5 rings containing 4 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@]12CCC(=O)C=C1C=C[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@@]21CCC(=O)O1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 5 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR, NR-AR-LBD, NR-Aromatase) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)CCc1c[nH]c2ccc(C[C@H]3COC(=O)N3)cc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 2 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(NC(Cc1cc(=O)[nH]c2ccccc12)C(=O)O)c1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC[C@H]1OC(=O)C[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](O)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)C(=O)C=CC(C)=C[C@@H]1CO[C@@H]1O[C@H](C)[C@@H](O)[C@@H](OC)[C@H]1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, moderately polar polycyclic system with 4 rings. MODERATE-RISK: reactive aldehyde. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[Si](Cn1cncn1)(c1ccc(F)cc1)c1ccc(F)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CO/N=C(\\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(C[N+]3(C)CCCC3)CS[C@H]12)c1csc(N)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 4 rings containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CO[C@]12C[C@@H](COC(=O)c3cncc(Br)c3)CN(C)[C@@H]1Cc1cn(C)c3cccc2c13 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 5 rings containing 3 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(O)[C@@H]1[C@H]2OC(=O)[C@@H]1[C@]1(O)C[C@H]3O[C@]34C(=O)O[C@H]2[C@]14C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic polycyclic system with 5 rings. HIGH-RISK FEATURES: epoxide ring (DNA alkylation risk). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=O)n1c(O)c(C(=O)c2cccs2)c2cc(Cl)ccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR) and cellular stress response (SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC[N+]1(CC)CCC(OC(=O)C(O)(c2ccccc2)c2ccccc2)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1CC2(CCCC2)CC(=O)N1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C(CCOCC1CO1)COCC1CO1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework. HIGH-RISK FEATURES: epoxide ring (DNA alkylation risk). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOc1cccc([C@]2(N3CCN(c4ccccc4)CC3)CC[C@@H](C)CC2)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)Cn1c(=O)n(Cc2ccc(Br)cc2F)c(=O)c2ccc(Cl)cc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1cccc(C[C@@H]2COc3ccc(OCc4nc5cc(F)ccc5s4)cc3[C@@H]2O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 5 rings containing 4 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)c1nnc2ccc(-c3ocnc3-c3cc(F)ccc3F)cn12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 4 rings containing 4 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NCC1(Cc2noc(=O)[nH]2)CCCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1cc2c3c(c1)C(c1ccccc1)=N[C@@H](NC(=O)c1cccnc1)C(=O)N3CC2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 5 rings containing 3 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1ccc(C2(c3ccc(O)cc3)c3ccccc3-c3ccccc32)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 5 rings containing 4 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The presence of these structural features suggests potential for cellular stress response (SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN1C(=CC=CC=Cc2sc3ccccc3[n+]2CC)Sc2ccccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: aniline moiety. these structural features indicate this compound may exhibit cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c1cnccn1)B(O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-ARE, SR-ATAD5, SR-HSE, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC[C@@]1(O)C[C@H](O[C@H]2C[C@H](N(C)C)[C@H](O[C@H]3C[C@H](O)[C@H](O[C@H]4CCC(=O)[C@H](C)O4)[C@H](C)O3)[C@H](C)O2)c2c(cc3c(c2O)C(=O)c2c(O)cccc2C3=O)[C@H]1C(=O)OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity polycyclic system with 7 rings containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-AR-LBD, NR-Aromatase, NR-ER) and cellular stress response (SR-MMP, SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(C(=O)c2c(C)n(CCN3CCOCC3)c3ccccc23)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings containing 3 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(-c2cc(=S)ss2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). The presence of these structural features suggests potential for cellular stress response (SR-ARE, SR-HSE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(CCCN1CCC(C(=O)c2ccc(F)cc2)CC1)c1ccc(F)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C1CC(COCC2CO2)CCC1COCC1CO1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings. HIGH-RISK FEATURES: epoxide ring (DNA alkylation risk). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1c(C(=O)c2cnn(C)c2O)ccc(S(C)(=O)=O)c1C1=NOCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 3 rings containing 2 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CS(=O)(=O)c1cc(C(F)(F)F)ccc1C(=O)c1cnoc1C1CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc2c3c1O[C@H]1[C@H](O)CC[C@H]4[C@@H](C2)N(C)CC[C@@]341 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 5 rings containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)N(C(=O)N1CO[C@@]2(C(=O)OC)Cc3cc(Cl)ccc3C2=N1)c1ccc(OC(F)(F)F)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). these structural features indicate this compound may exhibit nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(C=Cc1ccccc1)OCC=Cc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C1C[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]2(C)[C@@]1(OC(C)=O)C(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR) and cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCc1nc2cccnc2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 5 rings containing 5 aromatic ring(s). The presence of these structural features suggests potential for nuclear receptor activation (NR-PPAR-gamma) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(NS(C)(=O)=O)ccc1Nc1c2ccccc2nc2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 4 aromatic ring(s). MODERATE-RISK: aniline moiety. these structural features indicate this compound may exhibit cellular stress response (SR-MMP, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1OC[C@H](Cc2cccc(O)c2)[C@H]1Cc1cccc(O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CC2(C[C@H]1C(=O)O)SCCS2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), ester (metabolic deactivation pathway), amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)CNC(=NN=C(/C=C/c2ccc(C(F)(F)F)cc2)/C=C/c2ccc(C(F)(F)F)cc2)NC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 6 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR, NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C1=CC[C]([Ti+2][C]2=CC=CC2)=C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(NCNC(=O)NC1C(=O)NC(=O)N1CO)NC1C(=O)NC(=O)N1CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly hydrophilic bicyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OC[C@H]1O[C@@H](Oc2ccc(O)cc2)[C@H](O)[C@@H](O)[C@@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule c1cc[c]([Hg][c]2ccccc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar bicyclic framework containing 2 aromatic ring(s). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ATAD5, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1oc(C)c(C(=O)Nc2ccccc2)c1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-Aromatase) and cellular stress response (SR-ARE, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@]12CC[C@H](O)C[C@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](c3ccc(=O)oc3)C[C@H]3O[C@]132 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 6 rings containing 1 aromatic ring(s). HIGH-RISK FEATURES: epoxide ring (DNA alkylation risk). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER, NR-PPAR-gamma) and cellular stress response (SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(c1nccc(=O)[nH]1)C1CCN(c2nc3ccccc3n2Cc2ccc(F)cc2)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 5 rings containing 4 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1nc(=O)c(Br)c(-c2ccccc2)[nH]1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(-c2nc3cc(C4=NNC(=O)CC4C)ccc3[nH]2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings containing 3 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) and cellular stress response (SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)C3=CC[C@@]21C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR, NR-AR-LBD, NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(c1ccccc1)c1cc(-n2nc3ccccc3n2)c(O)c(C(C)(C)c2ccccc2)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic polycyclic system with 5 rings containing 5 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)c1c(N)sc2c1CCN(Cc1ccccc1)C2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)NC[C@H](O)COc1nsnc1N1CCOCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(CCCN1CCC(n2c(=S)[nH]c3ccccc32)CC1)c1ccc(F)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-Aromatase) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COC1CC(=C(c2cccs2)c2cccs2)C[N+](C)(C)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1ccc2nsnc2c1NC1=NCCN1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(c1ccc(F)cc1)C1CCN(CCn2c(=O)[nH]c3ccccc3c2=O)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](CC=C(C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)C=CC=C3CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic polycyclic system with 7 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)n1ncn(-c2ccc(N3CCN(c4ccc(OC[C@H]5CO[C@](Cn6cncn6)(c6ccc(Cl)cc6Cl)O5)cc4)CC3)cc2)c1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic polycyclic system with 7 rings containing 5 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(COc1ccccc1)N(CCCl)Cc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE, SR-HSE, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1CCOC(c2ccccc2)c2ccccc2C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1)Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule c1cc[c]([Bi]([c]2ccccc2)[c]2ccccc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C(=C/C=N/c1ccccc1)\\C=C\\Nc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC[N+](CC)(CCNC(=O)C(=O)NCC[N+](CC)(CC)Cc1ccccc1Cl)Cc1ccccc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)Nc1cccc(OC(=O)Nc2ccccc2)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc2c(c1)c1c3n2CCNC3CCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings containing 2 aromatic ring(s). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)Cc1nn(Cc2ccc(Br)cc2F)c(=O)c2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(N)no1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C=C\\C=C(C)\\C=C\\C=C(C)\\C=C\\C2=C(C)C(=O)CCC2(C)C)C(C)(C)CCC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic bicyclic framework. these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER, NR-ER-LBD) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc2c(c1)sc1ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc(S(=O)(=O)Nc2ccnn2-c2ccccc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc(-c2ccccn2)nc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)C(C)N(C(=O)Cc1ccccc1)c1c(C)cccc1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc2c(cc1OC)C(=O)CC2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOCCn1c(C2CCN(CCc3ccc(C(C)(C)C(=O)O)cc3)CC2)nc2ccccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 3 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc2c(cc1CC(=O)c1sccc1S(=O)(=O)Nc1onc(C)c1Cl)OCO2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1nc(C2CCCCC2)c(-c2ccc(S(N)(=O)=O)c(F)c2)o1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR-LBD) and cellular stress response (SR-HSE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CO[C@H]1C=CO[C@@]2(C)Oc3c(C)c(O)c4c(c3C2=O)C2=NC3(CCN(CC(C)C)CC3)NC2=C(NC(=O)C(C)=CC=C[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C4=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic polycyclic system with 6 rings containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cn1c(NCCN(CCO)CCCc2ccc([N+](=O)[O-])cc2)cc(=O)n(C)c1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar bicyclic framework containing 2 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)C[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H]1CCC(=O)N1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@@H]1C(=O)NCC(N)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic polycyclic system with 8 rings containing 6 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)CCNC(=O)C1C(C)=NC(/C=C2\\C(=O)Nc3ccc(F)cc32)=C1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@]12CCC(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)C=CC[C@@H]12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 4 rings. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCN(CCOc1c(Cl)cc(Cl)cc1Cl)C(=O)n1ccnc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR, NR-Aromatase) and cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule N=C(N)NCCCC[C@@H]1NC(=O)CCSSC[C@@H](C(N)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CC(=O)O)NC(=O)CNC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic polycyclic system with 4 rings containing 2 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=c1cccccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system containing 1 aromatic ring(s). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-Aromatase).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(C(=O)c1ccco1)c1ccco1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 2 aromatic ring(s). The presence of these structural features suggests potential for cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=c1[nH]cnc2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 2 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C1CS1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1[C@@H]2CC[C@H]1C[C@@H](OC(=O)C(CO)c1ccccc1)C2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOP(=O)(Sc1ccccc1)Sc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CSc1nc2cc(Cl)c(Oc3cccc(Cl)c3Cl)cc2[nH]1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C1=Cc2cccc3cccc1c23 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc(SSc2ccccc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). The presence of these structural features suggests potential for cellular stress response (SR-HSE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1nc(N)c2nc(-c3ccccc3)c(N)nc2n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: aniline moiety. these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-ATAD5, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(=O)N(c1ccccc1)C1CCN(Cc2cccs2)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1ccc([C@@H]2C[C@H]3CC[C@@H]2N3)cn1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule c1cnc2cc3c(cc2n1)C1CNCC3C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 4 rings containing 2 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE, SR-HSE, SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC[C@]12CCCN3CCc4c(n(c5ccccc45)[C@@](O)(C(=O)OC)C1)[C@@H]32 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 5 rings containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC[C@@H](O)C1C(=O)OC(C)[C@H](O)C=CC=CC=CC=CC=C(C)C(O)C(O)C(O)C[C@H](O)C[C@H](O)C[C@H](O)C[C@H](O)C[C@@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, moderately polar monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1c(Cl)cccc1-c1c[nH]cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER-LBD) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C/C(=C\\c1csc(C)n1)C1C[C@@H]2O[C@]2(C)CCC[C@H](C)C(O)[C@@H](C)C(=O)C(C)(C)[C@@H](O)CC(=O)O1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic polycyclic system with 3 rings containing 1 aromatic ring(s). HIGH-RISK FEATURES: epoxide ring (DNA alkylation risk). SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(C[C@@H]1NCCC[C@H]1O)Cn1cnc2cc(Br)c(Cl)cc2c1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1CCC[C@@H]1Cc1c[nH]c2ccc(CCS(=O)(=O)c3ccccc3)cc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings containing 3 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1CCN(C(=O)C2CCCCC2)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1CCC(O)(c2ccc(F)cc2)C(C(=O)c2ccc(F)cc2)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(COc1ccc(Cl)cc1)OCCNC12CC3CC(CC(C3)C1)C2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 5 rings containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1c(Cn2ccnc2)c2ccccc2n1CCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(CCN1CCC(c2ccccc2)C1)c1ccc2c(c1)OCCO2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings containing 2 aromatic ring(s). these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=C2C[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]2CC[C@]12O[C@@H]1C[C@H](C)CN[C@H]1[C@H]2C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 6 rings. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1C(CCS(=O)c2ccccc2)C(=O)N(c2ccccc2)N1c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(c1ccccc1)c1ccc(Nc2ccc(C(C)(C)c3ccccc3)cc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic polycyclic system with 4 rings containing 4 aromatic ring(s). MODERATE-RISK: aniline moiety. The presence of these structural features suggests potential for cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC12CCCC=C1C(=O)OC2=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)no1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN[C@@H]1[C@@H](O[C@H]2O[C@H](CO)[C@@H](N)[C@H](O)[C@H]2O)O[C@H]2C[C@@H](N)[C@@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](N)C[C@@H]3N)O[C@@H]2[C@@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic polycyclic system with 4 rings. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C#CCN1C(=O)COc2cc(F)c(N3C(=O)C4=C(CCCC4)C3=O)cc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 4 rings containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCOC(=O)COc1cc(N2C(=O)C3=C(CCCC3)C2=O)c(F)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)CSc1cc(/N=c2\\sc(=O)n3n2CCCC3)c(F)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1nn(C)c(Oc2ccccc2)c1/C=N/OCc1ccc(C(=O)OC(C)(C)C)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)N(C(=O)COc1nnc(C(F)(F)F)s1)c1ccc(F)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C1CN(P2(N3CC3)=NP(N3CC3)(N3CC3)=NP(N3CC3)(N3CC3)=N2)CCO1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 7 rings. Structural analysis reveals these structural features that correlate with cellular stress response (SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings containing 4 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) and cellular stress response (SR-ATAD5) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)CN(Cc1ccc(-c2ccccn2)cc1)NC(=O)[C@@H](NC(=O)OC)C(C)(C)C)C(C)(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)C[C@H](NC(=O)[C@H](CCc1ccccc1)NC(=O)CN1CCOCC1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity polycyclic system with 4 rings containing 2 aromatic ring(s). HIGH-RISK FEATURES: epoxide ring (DNA alkylation risk). SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit cellular stress response (SR-ARE, SR-ATAD5, SR-HSE, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C[C@@H]4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity polycyclic system with 7 rings containing 2 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC1CCOC(C)S1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1CCCCCCCCCCOCCCCO1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit nuclear receptor activation (NR-Aromatase) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN1C(=O)c2ccccc2C1Nc1ccc(OCCN2CCCCC2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)Nc1nc2cc(S(=O)c3ccccc3)ccc2[nH]1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR) and cellular stress response (SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1[nH]nc2c1N=C(c1ccccc1Cl)c1cc([N+](=O)[O-])ccc1N2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 3 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR, NR-Aromatase, NR-ER-LBD) and cellular stress response (SR-ARE, SR-ATAD5, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(S(C)=O)ccc1-c1nc2ncccc2[nH]1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C(c1ccc(C(=O)O)cc1)c1cc2c(cc1C)C(C)(C)CCC2(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-HSE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1C=CC(=O)N1c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for cellular stress response (SR-HSE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCc1ccc(OCC(=O)N2CCN(C(=O)COc3ccc(CCC)cc3OC)CC2)c(OC)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCn1c(=O)c2c(nc(/C=C/c3ccc(OC)c(OC)c3)n2C)n(CC)c1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccnc2c1CCCCC2S(=O)c1nc2ccccc2[nH]1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings containing 3 aromatic ring(s). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc(SCCSc2ccccc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3C(C)=CC[C@@H]4C[C@@H](C[C@]5(C=C[C@H](C)[C@@H](C6CCCCC6)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OCC(=CC=C[C@@H]3C)[C@]54O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic polycyclic system with 8 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(C(=O)N2CCCCCCC2)cc(OC)c1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1ccc(NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)c2ccccc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cccc(N(C)C(=S)Oc2ccc3c(c2)CCCC3)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR) and cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic polycyclic system with 4 rings containing 3 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=C\\c1ccccc1)/C=C1/SC(=S)N(CC(=O)O)C1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). The presence of these structural features suggests potential for cellular stress response (SR-ATAD5) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C#C[C@]1(O)C=C[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21CC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings. these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR, NR-AR-LBD, NR-ER, NR-ER-LBD) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1ccc(C(Cn2ccnc2)OCc2ccsc2Cl)c(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCNC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)C=C(C)[C@H](OC(N)=O)[C@@H](OC)C=CC=C(C)C(=O)NC(=CC1=O)C2=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity bicyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with cellular stress response (SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1c2cccc3c2[C@H](CCC3)CN1[C@@H]1CN2CCC1CC2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 6 rings containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[N+]1(C)CCCCC1COC(=O)C(O)(c1ccccc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)C(=O)CCSC(SCCC(=O)O)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-ATAD5).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(Nc1ccccc1)Nc1ccnc(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1c(-c2ccc(O)cc2)n(Cc2ccc(OCCN3CCCCCC3)cc2)c2ccc(O)cc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic polycyclic system with 5 rings containing 4 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The presence of these structural features suggests potential for nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COC[C@H](c1ccc(C(F)(F)F)cc1)N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@H]1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[N+]1(CCF)[C@@H]2CC[C@H]1C[C@@H](OC(=O)C(O)(c1ccccc1)c1ccccc1)C2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)C1=C(C)NC(C)=C(C(=O)O[C@H]2CCN(Cc3ccccc3)C2)[C@H]1c1cccc([N+](=O)[O-])c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings containing 2 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=C(C)C(=O)C(C(CCCCCC(=O)O)c2ccccc2)=C(C)C1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC[C@H]1C[C@@H]2C[C@H]3c4[nH]c5ccc(OC)cc5c4CCN(C2)[C@@H]13 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 6 rings containing 2 aromatic ring(s). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C1CN(CCOCCN2CCOCC2)CCO1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic bicyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc2c(c1)OC(C)(C)[C@@H](c1ccccc1)[C@@H]2c1ccc(OCCN2CCCC2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic polycyclic system with 5 rings containing 3 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(CN1c2ccccc2Sc2cccnc21)N(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCOC(C(=O)OC1CCN(C)CC1)(c1ccccc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(O)c2c(c1)O[C@@]1(C)CC[C@H]3C(C)(C)CCCC34CO[C@@H]2[C@H]41 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 5 rings containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)NCC(O)CSc1nc(-c2ccc(C(N)=O)s2)cs1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[N+]1(C)CCC(=C(c2ccccc2)c2ccccc2)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN1CCCC1CNC(=O)C(O)(c1ccccc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1cncn1CCN1CCOCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(OCCN1CCOCC1)c1cccnc1Nc1cccc(C(F)(F)F)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1[nH]cnc1-c1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1CC2CC1C1CCCC21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity polycyclic system with 3 rings. The presence of these structural features suggests potential for nuclear receptor activation (NR-AR) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=CCC2C(C1)C2(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)c1ccccc1S(=O)(=O)NC(=O)Nc1nc(C)cc(C)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOP(=O)(SC(C)CC)N1CCSC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity monocyclic system. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@@H](C6=CC(=O)OC6)CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)[C@H](O)[C@H](O)[C@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic polycyclic system with 6 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR-LBD, NR-Aromatase) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1C(=O)C[C@@H](C(=O)N[C@@H](Cc2c[nH]cn2)C(=O)N2CCC[C@H]2C(N)=O)NC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly hydrophilic polycyclic system with 3 rings containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc([C@@H]2c3cc4c(cc3C(O[C@@H]3O[C@@H]5COC(c6cccs6)O[C@H]5[C@H](O)[C@H]3O)C3COC(=O)[C@@H]32)OCO4)cc(OC)c1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity polycyclic system with 8 rings containing 3 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with cellular stress response (SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)C(/C=C\\C=C/C=C\\C=C2\\N(CCCCS(=O)(=O)O)c3ccc4ccccc4c3C2(C)C)=[N+](CCCCS(=O)(=O)[O-])c2ccc3ccccc3c21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 6 rings containing 4 aromatic ring(s). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc(S(=O)(=O)Nc2cnc3ccccc3n2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: aniline moiety. The presence of these structural features suggests potential for nuclear receptor activation (NR-AR) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(SCCNC=N)C[C@H]12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic bicyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity polycyclic system with 7 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCOC(Cn1ccnc1)c1ccc(Cl)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-Aromatase) and cellular stress response (SR-HSE, SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C#CCN1CC(=O)N(COC(=O)[C@@H]2[C@@H](C=C(C)C)C2(C)C)C1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1OC(=O)C2CCCCC12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1OC(=O)C2CC=CCC12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)c1ccc(CSc2cnn(C(C)(C)C)c(=O)c2Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(NCC1CCCCN1)c1cc(OCC(F)(F)F)ccc1OCC(F)(F)F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 6 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings. SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=C2N=C(C=C3N=C(C(C)=C4[C@@H](CCC(N)=O)[C@](C)(CC(N)=O)[C@](C)([C@@H]5N=C1[C@](C)(CCC(=O)NC[C@@H](C)OP(=O)([O-])O[C@H]1[C@@H](O)[C@@H](n6cnc7cc(C)c(C)cc76)O[C@@H]1CO)[C@H]5CC(N)=O)[N]4[Co+][C]#N)[C@@](C)(CC(N)=O)[C@@H]3CCC(N)=O)C(C)(C)[C@@H]2CCC(N)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity polycyclic system with 8 rings containing 2 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCN[C@H]1CCc2nc(N)sc2C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1CCC(=C2c3ccccc3CCc3sccc32)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 4 rings containing 2 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CO[C@@]1(NC(=O)C2SC(=C(C(N)=O)C(=O)O)S2)C(=O)N2C(C(=O)O)=C(CSc3nnnn3C)CS[C@@H]21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic polycyclic system with 4 rings containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CO/N=C(\\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(CSc3nnnn3C)CS[C@H]12)c1csc(N)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(Nc1ccc(S(=O)(=O)N2CCOCC2)cc1)c1cc(Cl)ccc1NS(=O)(=O)c1ccc(Cl)s1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for cellular stress response (SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc2[nH]c(C)c(CCN3CCN(c4ccccc4)CC3)c2cc1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[N+](C)(CCCCCC[N+](C)(C)C1c2ccccc2-c2ccccc21)C1c2ccccc2-c2ccccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 6 rings containing 4 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(C2NC(=S)N3C(c4ccc(OC)c(OC)c4)NC(=S)N23)cc1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings containing 2 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1CCCCCCCCCCCCCCO1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1C(C(=O)Nc2ccccn2)C(=O)c2sc(Cl)cc2S1(=O)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1C(Cl)C(CCl)CN1c1cccc(C(F)(F)F)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 5 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC[C@H]1CN(CC2CCOCC2)C(=O)OC12CCN(C1(C)CCN(C(=O)c3c(C)ncnc3C)CC1)CC2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic polycyclic system with 5 rings containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CS(=O)(=O)c1ccc([C@@H](C[C@H]2CCC(=O)C2)C(=O)Nc2cnccn2)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)C(=O)c1cc(S(=O)(=O)Cc2ccccc2)c(N2CCC(c3ccccc3)CC2)cc1N(CC)CCN(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(NS(=O)(=O)/C=C/c1ccccc1)c1ccc(F)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for cellular stress response (SR-ATAD5, SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1C(=O)N(c2ccccc2Br)Cc2cnc(Nc3ccc4c(c3)OCC(CO)O4)nc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 5 rings containing 3 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(NS(=O)(=O)/C=C/c1cccs1)c1ccc(F)cc1Br for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) and cellular stress response (SR-ATAD5, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 5 rings containing 3 aromatic ring(s). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCc1cccc(=O)o1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule NC[C@H]1CC[C@H](C(=O)Oc2ccc(CCC(=O)O)cc2)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-Aromatase).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@]12C=CC(=O)N[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](C(=O)Nc3cc(C(F)(F)F)ccc3C(F)(F)F)CC[C@@H]12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 5 rings containing 1 aromatic ring(s). MODERATE-RISK: 6 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)O)CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 5 rings containing 4 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR) and cellular stress response (SR-ATAD5, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(-c2ncc(Cl)cc2-c2ccc(S(C)(=O)=O)cc2)cn1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@H](Cc1ccccc1)NC(=O)[C@H](C(C)C)N1CCCNC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic polycyclic system with 4 rings containing 3 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for cellular stress response (SR-ARE, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2N(CCCCn3cnc(-c4cccnc4)c3)C(=O)O[C@]12C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic polycyclic system with 5 rings containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: aniline moiety. these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR, NR-AhR, NR-Aromatase) and cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)Nc1nc2cc(Sc3ccccc3)ccc2[nH]1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR-LBD, NR-AhR, NR-ER) and cellular stress response (SR-ATAD5, SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC1=C(C)CN(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3)cc2)C1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cnc(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NC3CCCCC3)cc2)cn1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=O)c1nc(-c2cccc(-c3cc(F)ccc3OCC(F)(F)C(F)(F)F)c2)n[nH]1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 6 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc2c(cc1C(F)(F)F)N(C(=O)Nc1ccc(Oc3cccnc3C)nc1)CC2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for cellular stress response (SR-ARE, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN1CCC2(CC1)COc1cc3c(cc12)N(C(=O)c1ccc(-c2ccc(-c4nnc(C)o4)cc2C)cc1)CC3 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic polycyclic system with 7 rings containing 4 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2C[C@H](N(C)[C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 5 rings containing 3 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OCC(CO)n1cnc(-c2ccc(F)cc2)c1-c1ccnc(Oc2ccccc2)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings containing 4 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1nc(-c2ccc3c(c2)CCN(CCC2CCC(NC(=O)/C=C/c4ccc(F)cc4)CC2)CC3)no1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic polycyclic system with 5 rings containing 3 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR-LBD, NR-ER-LBD) and cellular stress response (SR-ATAD5, SR-HSE, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule OC(c1ccccc1)(c1ccccc1)C1CN2CCC1CC2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 5 rings containing 2 aromatic ring(s). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(CCCN1CCN2CCCC2C1)c1ccc(F)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(CNC(=O)c1cccnc1)NC(=O)c1cccnc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NNC(=O)CP(=O)(c1ccccc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(CN1CCN(CC(C)C(=O)c2ccccc2)CC1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(O)c(C(=O)N[C@@H](C(=O)N[C@@H]2C(=O)N3C(C(=O)O)=C(CSc4nnnn4C)CS[C@H]23)c2ccc(O)cc2)cn1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, moderately polar polycyclic system with 5 rings containing 3 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1C2CC(CC2C2CCCC(O)C2)C1(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings. these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=CCC(C(C)C)=CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule ON=C1CCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc2sc(SNC3CCCCC3)nc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-HSE, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 5 rings. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-AR, NR-AR-LBD) and cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity monocyclic system. SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CSc1ccc(C(=O)C(C)(C)N2CCOCC2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER, NR-ER-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1Cc2c(N)cccc2C(c2ccccc2)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(c1ccccc1)C1(O)CCCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@H]1N=C(N)O[C@H]1c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(Cc1ccccc1)NCCn1cnc2c1c(=O)n(C)c(=O)n2C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 3 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)C1[O][Sb]2[O]C(=O)C([O]2)C(C(=O)O)[O][Sb]2[O]C(=O)C1[O]2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic polycyclic system with 3 rings. SAFETY FEATURES: carboxylic acid (promotes excretion). The presence of these structural features suggests potential for cellular stress response (SR-ARE, SR-HSE, SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cccc2c1cc([N+](=O)[O-])c1c(C(=O)O)cc3c(c12)OCO3 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings containing 3 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). SAFETY FEATURES: carboxylic acid (promotes excretion). The presence of these structural features suggests potential for cellular stress response (SR-ARE, SR-MMP, SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccccc1CNc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: aniline moiety. The presence of these structural features suggests potential for nuclear receptor activation (NR-Aromatase) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCn1ccnc1CC1COc2ccccc2O1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1N(c2ccccc2)c2ccccc2C1(Cc1ccncc1)Cc1ccncc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 5 rings containing 4 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1CCC(c2ccc(-n3ccnc3)cc2)=NN1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 2 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-Aromatase) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc2c(c1)OCC(C1=NCCN1)O2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 1 aromatic ring(s). these structural features indicate this compound may exhibit cellular stress response (SR-ARE, SR-HSE, SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccccc1N1C(=O)c2cc(S(N)(=O)=O)c(Cl)cc2NC1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C(=O)O)c1ccc(CC2CCCC2=O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(CN(C)C)CN1c2ccccc2S(=O)(=O)c2ccccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1c(N)nc(C(CC(N)=O)NCC(N)C(N)=O)nc1C(=O)NC(C(=O)NC(C)C(O)C(C)C(=O)NC(C(=O)NCCc1nc(-c2nc(C(=O)NCCCN[C@@H](C)c3ccccc3)cs2)cs1)C(C)O)C(O[C@@H]1O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](OC(N)=O)[C@@H]1O)c1c[nH]cn1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic polycyclic system with 7 rings containing 5 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit cellular stress response (SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1O[C@@H]2[C@@H](O)[C@H](O)O[C@@H]2[C@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic bicyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCc1cc2c(=O)c(C(=O)OC)c[nH]c2cc1OCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)CCc1c[nH]c2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). The presence of these structural features suggests potential for cellular stress response (SR-HSE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity polycyclic system with 6 rings containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). these structural features indicate this compound may exhibit cellular stress response (SR-MMP, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(c1ccc2c(c1)C(=O)OC2=O)c1ccc2c(c1)C(=O)OC2=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 4 rings containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(COc1ccc(Cl)cc1)N1CCN(Cc2ccc3c(c2)OCO3)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)CCC[C@]2(C)[C@H]3CCO[C@]3(C)CC[C@@H]12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings. The presence of these structural features suggests potential for cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=c1[nH]c(=O)c2c[nH]nc2[nH]1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic bicyclic framework containing 2 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)C1=C(C)NC(C)=C(C(=O)OCCc2ccc(N3CCN(C(c4ccccc4)c4ccccc4)CC3)cc2)C1c1cccc([N+](=O)[O-])c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 6 rings containing 4 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=S(=O)(O)c1ccccc1C=Cc1ccc(-c2ccc(C=Cc3ccccc3S(=O)(=O)O)cc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 4 rings containing 4 aromatic ring(s). Structural analysis reveals these structural features that correlate with cellular stress response (SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC[C@@H](C)[C@@H](N)C1=N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C(=O)N[C@@H]2CCCCNC(=O)[C@@H](CC(N)=O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](Cc3cnc[nH]3)NC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@@H]([C@H](C)CC)NC(=O)[C@@H](CCCN)NC2=O)[C@@H](C)CC)CS1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic polycyclic system with 4 rings containing 2 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)C(O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, moderately polar polycyclic system with 12 rings containing 5 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN1CN(CC)CN(CC)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=c1oc(=O)c2cc3c(=O)oc(=O)c3cc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic polycyclic system with 3 rings containing 3 aromatic ring(s). The presence of these structural features suggests potential for cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1CCCC(CC2c3ccccc3Sc3ccccc32)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 4 rings containing 2 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN[C@@H]1[C@H](O)[C@H](NC)[C@H]2O[C@@]3(O)C(=O)C[C@@H](C)O[C@H]3O[C@@H]2[C@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic polycyclic system with 3 rings. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNC(=O)c1c(I)c(C(=O)NCC(=O)Nc2c(I)c(C(=O)O)c(I)c(C(=O)NCCO)c2I)c(I)c(N(C)C(C)=O)c1I for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 6 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 5 rings containing 3 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-PPAR-gamma).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCN1C(=O)C(CC(C)C)NC1=S for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)CC/C=C\\CC[C@@H]1[C@@H](N2CCCCC2)[C@@H](O)C[C@@H]1OCc1ccc(-c2ccccc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 2 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1c2ccccc2S(=O)(=O)N1CCCCN1CCN(c2ncccn2)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@@H]1CN(CCCn2c3ccccc3c3ccccc32)C[C@H](C)N1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings containing 3 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C(=O)c1c(O)c2ccccc2n(C)c1=O)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(N)c(Cl)cc1C(=O)NC1CN2CCC1CC2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 4 rings containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(c2ccccc2)OC(C(=O)O)=CC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule S=C(SSC(=S)N1CCCCC1)N1CCCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework. The presence of these structural features suggests potential for nuclear receptor activation (NR-ER-LBD) and cellular stress response (SR-ATAD5) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)NNc1ccc(N(CC)CC(C)O)nn1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1CCCCCN1SSN1CCCCCC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework. SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for cellular stress response (SR-HSE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(Cc1ccccc1)OCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc(CSCc2ccccc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule c1cc(N(CC2CO2)CC2CO2)ccc1Cc1ccc(N(CC2CO2)CC2CO2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 6 rings containing 2 aromatic ring(s). HIGH-RISK FEATURES: epoxide ring (DNA alkylation risk). MODERATE-RISK: aniline moiety. The presence of these structural features suggests potential for cellular stress response (SR-ARE, SR-ATAD5, SR-HSE, SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1CCCCCCCCCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cccc(N(C)C(=S)Oc2ccc3c(c2)C2CCC3C2)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=O)C1(N2CCCCC2)CCN(CCCC(=O)c2ccc(F)cc2)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)CCOc1ccc(C(O)(Cc2ccc(Cl)cc2)c2ccc(C)cc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1CCCCC1C1CCCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C([C@H]3CCCO3)S[C@H]12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1C[C@@H]2C[C@H]1CN2c1cc2c(cc1F)c(=O)c(C(=O)O)cn2C1CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 5 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@@H](O)[C@H]1C(=O)N2C(C(=O)[O-])=C(SC3Cn4cnc[n+]4C3)[C@H](C)[C@H]12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly hydrophilic polycyclic system with 4 rings containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(CS(=O)Cc1ccco1)NC/C=C\\COc1cc(CN2CCCCC2)ccn1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C/C(=C\\C(=O)OCCCCCCCCC(=O)O)C[C@@H]1OC[C@H](C[C@@H]2O[C@H]2[C@@H](C)[C@H](C)O)[C@@H](O)[C@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity bicyclic framework. HIGH-RISK FEATURES: epoxide ring (DNA alkylation risk). SAFETY FEATURES: carboxylic acid (promotes excretion), ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@]4(C)CC[C@@H]1C32OO4 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 5 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=O)N(O)[C@@H]1C=C[C@H](Oc2cccc(Oc3ccc(F)cc3)c2)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) and cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=O)N1C(=O)C(C(=O)c2cc(Cl)cs2)c2cc(F)c(Cl)cc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) and cellular stress response (SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CNC(=O)[C@H]1O[C@@H](n2cnc3c(NCc4cc(Cl)ccc4OCc4cc(C)no4)ncnc32)[C@H](O)[C@@H]1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, moderately polar polycyclic system with 5 rings containing 4 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(NC(=O)C(=O)O)cc(C)c1Oc1ccc(O)c2c1CCC2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1oc(-c2ccccc2)nc1CCOc1cccc2c1ccn2CCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 4 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). The presence of these structural features suggests potential for nuclear receptor activation (NR-PPAR-gamma) and cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)C1(c2ccc3c(c2)OC[C@H](Cc2ccc(-c4ccccc4)cc2)[C@H]3O)CCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 5 rings containing 3 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1c(-c2cccnc2)c2ccccc2n1CCCCC(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCc1nn(C)c(C(=O)NCc2ccc(C(C)(C)C)cc2)c1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE, SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Fc1ccc(C(OCCN2CCN(CCCc3ccccc3)CC2)c2ccc(F)cc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 4 rings containing 1 aromatic ring(s). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC1(c2cnc[nH]2)Cc2ccccc2C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCc1c(OCCCCc2nnn[nH]2)ccc(C(C)=O)c1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The presence of these structural features suggests potential for nuclear receptor activation (NR-PPAR-gamma) and cellular stress response (SR-MMP, SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(Oc1ccccc1)c1ccc2ccccc2c1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit cellular stress response (SR-ATAD5) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule ON=C1CCCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCc1c2oc(C(=O)O)cc(=O)c2cc2c(=O)cc(C(=O)O)n(CC)c12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C(=O)CCCOc1ccc2[nH]c(=O)ccc2c1)C1CCCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit cellular stress response (SR-ATAD5) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(N)c2ccccc2[n+]1CCCCCCCCCC[n+]1c(C)cc(N)c2ccccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic polycyclic system with 4 rings containing 4 aromatic ring(s). MODERATE-RISK: aniline moiety. The presence of these structural features suggests potential for nuclear receptor activation (NR-Aromatase) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CSc1ccc(C(=O)c2[nH]c(=O)[nH]c2C)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC1(C2=NCCN2)Cc2ccccc2O1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 1 aromatic ring(s). The presence of these structural features suggests potential for cellular stress response (SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC#CCC(C)[C@H](O)/C=C/[C@@H]1[C@H]2c3cccc(CCCC(=O)O)c3O[C@H]2C[C@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C/C(=C(\\CCOC(=O)c1ccccc1)SS/C(CCOC(=O)c1ccccc1)=C(/C)N(C=O)Cc1cnc(C)nc1N)N(C=O)Cc1cnc(C)nc1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 4 rings containing 4 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC(=O)N1CCCN(c2nc(N)c3cc(OC)c(OC)cc3n2)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(Cc1ccc(C(C)(C)C)cc1)Cc1cccc2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CO/N=C(/C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(C[n+]3ccn4ncccc43)CS[C@H]12)c1nsc(N)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic polycyclic system with 5 rings containing 3 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCOC(=O)C(C)(C)OC(=O)c1cc(-n2c(=O)cc(C(F)(F)F)n(C)c2=O)ccc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CO/C=C(/C(=O)OC)c1ccccc1Oc1cc(Oc2ccccc2C#N)ncn1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccccc1N1CCN(CCCNc2cc(=O)n(C)c(=O)n2C)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(/C=C/C(=O)CC(=O)/C=C/c2ccc(O)c(OC)c2)ccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER, NR-PPAR-gamma) and cellular stress response (SR-ARE, SR-HSE, SR-MMP, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1CCCC(=O)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)CCN1CCN(c2cccc(Cl)c2)C1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1ccc(C(Cn2ccnc2)OCc2ccc(Sc3ccccc3)cc2)c(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic polycyclic system with 4 rings containing 4 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule NS(=O)(=O)c1cc(C(=O)NN2C[C@H]3[C@H]4CCC(C4)[C@H]3C2)ccc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 4 rings containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C/C(=C(/OCCOc1ccc(Cl)cc1)c1ccc(Cl)cc1Cl)n1ccnc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with cellular stress response (SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc2[nH]c(SCc3ncc(C)c(OC)c3C)nc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule [Cl][V]([Cl])([CH]1C=CC=C1)[CH]1C=CC=C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework. MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)[C@@H](C(=O)O)C(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1ccc2cc(SSc3ccc4cc(O)ccc4c3)ccc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic polycyclic system with 4 rings containing 4 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-ARE, SR-HSE, SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1CCCC=CCCCCCCCCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-PPAR-gamma) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1CCC(N(Cc2ccccc2)c2ccccc2)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=NN(c2ccc(C)c(C)c2)C(=O)/C1=N/Nc1cccc(-c2cccc(C(=O)O)c2)c1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). The presence of these structural features suggests potential for cellular stress response (SR-HSE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=NC(C)OC1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 8 rings containing 5 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-MMP, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CO[C@H]2OCC[C@H]21)S(=O)(=O)c1ccc(N)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1CC(=O)N=C1NC(=O)Nc1cccc(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=[N+]([O-])c1ccc2[nH]ncc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 2 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C1=CCCC=CCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N=C1NC(=N)c2cc3ccccc3cc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR-LBD, NR-AhR) and cellular stress response (SR-ARE, SR-ATAD5, SR-HSE, SR-MMP, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CO/N=C(/C1=NOCCO1)c1ccccc1Oc1ncnc(Oc2ccccc2Cl)c1F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for cellular stress response (SR-ARE, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=CC(=O)[C@H]2C[C@@H]1C2(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity polycyclic system with 3 rings. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCN(CCc1cccs1)[C@H]1CCc2c(O)cccc2C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CCCCOC(=O)c1ccc(OC)c(OC)c1)C(C)Cc1ccc(OC)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cccc(C)c1NC(=O)CN1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)C1CC(=O)C(=C(O)C2CC2)C(=O)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1cccc(-c2noc(-c3ccccc3F)n2)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR, NR-AhR, NR-ER) and cellular stress response (SR-ATAD5).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[N+]1(C)CCC(OC(=O)C(O)(c2ccccc2)C2CCCC2)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CSC1=N[C@@](C)(c2ccccc2)C(=O)N1Nc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc2c(c1)ccc1cc3c(ccc4ccccc43)cc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly lipophilic polycyclic system with 5 rings containing 5 aromatic ring(s). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-ER-LBD) and cellular stress response (SR-ARE, SR-ATAD5, SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@@H]1CC[C@H]2C(C)(C)[C@H]3C[C@@]12CC[C@@]3(C)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings. these structural features indicate this compound may exhibit cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=S1OCCO1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc2c(cc1OC)-c1c/c(=N\\c3c(C)cc(C)cc3C)n(C)c(=O)n1CC2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings containing 3 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OC(CCN1CCCCC1)(c1ccccc1)C1CCCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)CC3OC1CC(N2CCOC(OC)C2)C(O)C(C)O1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, moderately polar polycyclic system with 6 rings containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OC(c1ccc(Cl)cc1)(c1ccc(Cl)cc1)c1cccnc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-MMP, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1C(=O)/C(=N/NC(N)=S)c2ccccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR, NR-PPAR-gamma) and cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(Nc1ccc2[nH]ccc2c1)c1cc2cc(F)ccc2n1Cc1cccc(F)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 5 rings containing 5 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(N[C@H](c1ccccc1)[C@@H]1CN2CCC1CC2)c1c(Cl)ccc(C(F)(F)F)c1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 5 rings containing 2 aromatic ring(s). MODERATE-RISK: 5 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)CCC=C1c2ccccc2C(C)(C)c2ccccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). The presence of these structural features suggests potential for nuclear receptor activation (NR-Aromatase) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)COc1ccc2c(c1)CC(NCC(O)c1cccc(Cl)c1)CC2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(C(C)C)c2c(c1)S(=O)(=O)N(COc1cc(=O)n3cccc(OCCN4CCCCC4)c3n1)C2=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity polycyclic system with 5 rings containing 3 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR-LBD) and cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(-c2nc(NC(=O)c3cc4cc(C)cc(C)c4n3CC(=O)O)sc2CCC2CCCCC2)c(OC)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 5 rings containing 4 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). these structural features indicate this compound may exhibit cellular stress response (SR-HSE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(C(=O)Nc2ccc(S(=O)(=O)O)c3cc(S(=O)(=O)O)cc(S(=O)(=O)O)c23)cc1NC(=O)c1cccc(NC(=O)Nc2cccc(C(=O)Nc3cc(C(=O)Nc4ccc(S(=O)(=O)O)c5cc(S(=O)(=O)O)cc(S(=O)(=O)O)c45)ccc3C)c2)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 8 rings containing 8 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 5 rings containing 1 aromatic ring(s). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR, NR-AR-LBD, NR-Aromatase, NR-ER, NR-ER-LBD) and cellular stress response (SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@@H]3C(=O)C[C@@H]4CC(=O)CC[C@]4(C)[C@H]3CC(=O)[C@]12C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings. SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule c1cc[n+]2c(c1)-c1cccc[n+]1CC2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar polycyclic system with 3 rings containing 2 aromatic ring(s). these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)O)[C@H]21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework. SAFETY FEATURES: carboxylic acid (promotes excretion), ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)CN[C@@H](C(=O)N1CC[C@H]1C(=O)NCc1ccc(/C(N)=N/O)cc1)C1CCCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 3 rings containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C(=O)O)c1ccc(C2CCCCC2)c2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C(=O)O)c1ccc2c(c1)CC(=O)c1ccccc1S2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). The presence of these structural features suggests potential for nuclear receptor activation (NR-PPAR-gamma) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1OC(=O)C(C)OC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(S(=O)(=O)N2c3ccc(Cl)cc3[C@@](O)(c3ccccc3Cl)[C@H]2C(=O)N2CCC[C@@H]2C(N)=O)cc1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity polycyclic system with 5 rings containing 3 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(CCN(C)CCCN2CCc3cc(OC)c(OC)cc3CC2=O)cc1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)c1ccco1)C(=O)CCl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic polycyclic system with 5 rings containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR) and cellular stress response (SR-ARE, SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule ClC1(Cl)C2(Cl)C3(Cl)C4(Cl)C(Cl)(Cl)C5(Cl)C3(Cl)C1(Cl)C5(Cl)C24Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 6 rings. MODERATE-RISK: 12 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CO[C@@]12[C@H](COC(N)=O)C3=C(C(=O)C(C)=C(N)C3=O)N1C[C@@H]1N[C@@H]12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic polycyclic system with 4 rings. SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with cellular stress response (SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc2c(C(=O)c3ccc(Cl)cc3)c(C)n(CC(=O)O)c2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(=O)O[C@H]1[C@@H](N2CCCCC2)C[C@H]2[C@@H]3CC[C@H]4C[C@H](OC(C)=O)[C@@H](N5CCCCC5)C[C@]4(C)[C@H]3CC[C@@]21C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 6 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc2c(CCC3CCNCC3)c[nH]c2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cn1cc(S(C)=O)c(=O)c2ccc(F)cc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOCn1c(-c2ccc(Cl)cc2)c(C#N)c(Br)c1C(F)(F)F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 5 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with cellular stress response (SR-HSE, SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(C(=O)N2CCCC2=O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@H]1NCc2cc(-c3ccc4c(=O)c(C(=O)O)cn(C5CC5)c4c3OC(F)F)ccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 5 rings containing 3 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(OC)nc(Oc2cccc(Oc3nc(OC)cc(OC)n3)c2C(=O)O)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1oc(=O)oc1COC(=O)[C@@H]1N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 4 rings containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccc(C(=O)N2CC3CC(CN(Cc4ccccc4)C3)C2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)CCC(C)(C)c2cc(C(=O)Nc3ccc(C(=O)O)cc3)ccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). The presence of these structural features suggests potential for cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(COc2ccc(CC3SC(=O)NC3=O)cc2)CCCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-Aromatase, NR-PPAR-gamma) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ncnc2c1ncn2Cc1c(F)cccc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)Cc1ccc2c(c1)C(=O)c1ccccc1CO2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(C(C)OC(=O)C2(C)CCC(C(=O)O)C2(C)C)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N#CC1(c2ccc(F)cc2)CCC(=O)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC(C)C1N=C(C)C(C)S1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=CCc1ccc(OC(=O)Cc2ccccc2)c(OC)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)CCN(Cc1cccs1)c1ccccn1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1snc(Cl)c1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cnc(C(=O)O)c[n+]1[O-] for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(c1cc2ccccc2o1)N1CCN(Cc2ccccc2)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings containing 3 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOc1cc(N)c(Cl)cc1C(=O)NCC1CN(Cc2ccc(F)cc2)CCO1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[N@+]12CCCC[C@@H]1CCC(=C(c1cccs1)c1cccs1)C2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 4 rings containing 2 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1NC2NC(=O)NC2N1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic bicyclic framework. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1N=C2SCCN2C(=O)C1Cc1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc2sc(SSN3CCOCC3)nc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-PPAR-gamma) and cellular stress response (SR-HSE, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@@H]1CC[C@@]2(OC1)O[C@H]1C[C@H]3[C@@H]4CC[C@H]5C[C@@H](O)CC[C@]5(C)[C@H]4CC(=O)[C@]3(C)[C@H]1[C@@H]2C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 6 rings. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=C2[C@H]3OC(=O)[C@@H](C)[C@@H]3CC[C@@]2(C)C=CC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cccc(N(C)C(=S)Oc2ccc3ccccc3c2)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc2c(c1)CCCC2C1=NCCN1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=c1ccc2cc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c(O)cc2o1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[N+]1(C)CCN(CC(O)(c2ccccc2)C2CCCCC2)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1C(=O)C(C)(C2=CCCCC2)C(=O)N=C1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](OCCc3ccc(O)c(O)c3)O[C@H](CO[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H]2OC(=O)/C=C/c2ccc(O)c(O)c2)[C@H](O)[C@H](O)[C@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic polycyclic system with 5 rings containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)C(=O)OCC(=O)[C@@]12O[C@H](C3CCCCC3)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]12C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic polycyclic system with 6 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR) and cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1c2ccccc2CCc2ccccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1[C@@H]2CC[C@H]1C[C@@H](O)C2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC[C@@H](C)CCCCC(=O)N[C@@H](CCNCS(=O)(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCNCS(=O)(=O)O)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCNCS(=O)(=O)O)NC(=O)[C@H](CCNCS(=O)(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCNCS(=O)(=O)O)NC1=O)[C@@H](C)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic monocyclic system. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(OOC(=O)c1ccccc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc2c(c1)[nH]c1cnccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1CC(OC(=O)C(O)c2ccccc2)CC(C)(C)N1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1NS(=O)(=O)c2ccccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1cc(/N=N/c2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1[C@@H]2C[C@@H](OC(=O)[C@H](CO)c3ccccc3)C[C@H]1[C@@H]1O[C@@H]12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 4 rings containing 1 aromatic ring(s). HIGH-RISK FEATURES: epoxide ring (DNA alkylation risk). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule FC(F)(F)C(=NOCC1OCCO1)c1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@@H](C1=C(CCN(C)C)Cc2ccccc21)c1ccccn1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OC[C@H]1O[C@@H](OCCc2ccc(O)cc2)[C@H](O)[C@@H](O)[C@@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1c2ccccc2-c2n[nH]c3cccc1c23 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings containing 3 aromatic ring(s). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)c1ccc(C#Cc2ccc3c(c2)C(C)(C)CCS3)nc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-Aromatase) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CNC1CCCN(c2c(F)cc3c(=O)c(C(=O)O)cn(C4CC4)c3c2OC)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@H]1COc2c(C3(N)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCc1nc(C)c2c(=O)nc(-c3cc(S(=O)(=O)N4CCN(CC)CC4)ccc3OCC)[nH]n12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings containing 3 aromatic ring(s). these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc2c(cc1OC)C(=O)C(CC1CCN(Cc3ccccc3)CC1)C2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 2 aromatic ring(s). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule NS(=O)(=O)c1cc2c(cc1Cl)NC(CC1CCCC1)NS2(=O)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 3 rings containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)Oc1ccc(C(=C2CCCCC2)c2ccc(OC(C)=O)cc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)S[C@@H]2[C@H](NC(=O)C3(N)CCCCC3)C(=O)N2[C@H]1C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N#C[C@@H]1C[C@@H]2C[C@@H]2N1C(=O)[C@@H](N)C12CC3CC(CC(O)(C3)C1)C2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 6 rings. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(N[C@@H](c1ccccc1)[C@@H]1CCCCN1)c1cccc(C(F)(F)F)c1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cccc(-c2ccc(/C=C\\CN3CCCCCC3)cc2Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C/C=C1\\[C@H]2C=C(C)C[C@]1(N)c1ccc(=O)[nH]c1C2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](O)O[C@@H]3CO)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1N[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic polycyclic system with 4 rings. The presence of these structural features suggests potential for nuclear receptor activation (NR-ER, NR-ER-LBD) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@]1(Cn2ccnn2)[C@H](C(=O)O)N2C(=O)C[C@H]2S1(=O)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic polycyclic system with 3 rings containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(/C=C/C=C/c1ccc2c(c1)OCO2)N1CCCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-ARE, SR-ATAD5) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)Nc1c(I)c(C(=O)N[C@H]2C(O)O[C@H](CO)[C@@H](O)[C@@H]2O)c(I)c(N(C)C(C)=O)c1I for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C(=O)c1cccnc1)c1cccnc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1CCN2c3ccccc3Cc3ccccc3C2C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1nc2sccn2c(=O)c1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 5 rings containing 4 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(c1ccc(F)cc1)C1CCN(CCn2c(=S)[nH]c3ccccc3c2=O)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1C[C@@H]2OCC=C3CN4CC[C@]56c7ccccc7N1[C@H]5[C@H]2[C@H]3C[C@H]46 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 7 rings containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)CCC=C1c2ccccc2C=Cc2ccccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(OOC(C)(C)c1ccccc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER, NR-ER-LBD) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(CC1(C)CCCO1)S(=O)(=O)c1ccc(Cl)c(S(N)(=O)=O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CO[C@]1(NC(=O)CSC(F)F)C(=O)N2C(C(=O)O)=C(CSc3nnnn3CCO)CO[C@H]21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly hydrophilic polycyclic system with 3 rings containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1NC2CCCCN2C12CCN(CCCN1c3ccccc3CCc3ccc(Cl)cc31)CC2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 6 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule N[C@H]1CN(c2c(F)cc3c(=O)c(C(=O)O)cn(C4C[C@H]4F)c3c2Cl)CC12CC2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 5 rings containing 2 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)O[C@@H]1C(=O)O[C@@H]2[C@H]1OC(=O)[C@@H]2OC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic bicyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C(O)c1ccccc1)N(C)CCOC(c1ccccc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)c1ccc(NC(=O)CN2CCCCC2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)O[C@H]1CC[C@@]2(C)C(=CC[C@@H]3[C@@H]2CC[C@]2(C)C(C(C)=O)=CC[C@@H]32)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C(O)c1ccccc1)N(C)C/C=C/c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@H]43)[C@@H]1CC[C@@H]2OC(=O)CCC1CCCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic polycyclic system with 5 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule c1cc(CCCc2ccncc2)ccn1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). these structural features indicate this compound may exhibit nuclear receptor activation (NR-Aromatase) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(CCNCC(O)COc2cccc(C)c2)cc1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O[C@H]3[C@H](O)[C@@H](O)[C@@H](O)O[C@@H]3CO)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic polycyclic system with 3 rings. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AR, NR-AR-LBD, NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic polycyclic system with 5 rings containing 4 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic polycyclic system with 4 rings containing 4 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNC(=O)c1cnn(-c2nc(N)c3ncn([C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O)c3n2)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly hydrophilic polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1Nc2cc(Cl)ccc2Oc2ccccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)Nc1nc2cc(C(=O)C3CC3)ccc2[nH]1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC12COCN1COC2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(OC(=O)N(CC(=O)O)Cc2ccc(OCCc3nc(-c4ccccc4)oc3C)cc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic polycyclic system with 4 rings containing 4 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C1=CCC(c2ccccc2)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=C(C)S(=O)(=O)CCS1(=O)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system. The presence of these structural features suggests potential for nuclear receptor activation (NR-Aromatase, NR-PPAR-gamma) and cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)Nc1ccc(OCCOCCOc2ccc(NC(C)=O)cc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(NNC(=O)c1ccccc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) and cellular stress response (SR-ATAD5, SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc(OCc2ccc(CCCN3CCOCC3)cc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=S(c1cc(Cl)cc(Cl)c1O)c1cc(Cl)cc(Cl)c1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). Structural analysis reveals these structural features that correlate with cellular stress response (SR-HSE, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(Nc1ccc(Oc2ccc(Cl)cc2)c(Cl)c1)c1cc(I)cc(I)c1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-HSE, SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1c2c(nc3c1CCC3)CCCC2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity polycyclic system with 3 rings containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CO/N=C(\\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(CSc3nc(C)c(CC(=O)O)s3)CS[C@H]12)c1csc(N)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, moderately polar polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)Cn1c(C(=O)Nc2nc(-c3ccccc3Cl)cs2)cc2ccccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 4 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-PPAR-gamma) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=c1[nH]c(=O)n(Cl)c(=O)n1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1c(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc2c(c1OC)-c1ccc(SC)c(=O)cc1[C@@H](NC(C)=O)CC2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, moderately polar polycyclic system with 4 rings containing 2 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1occc1C(=O)Nc1ccc(C(=O)N2CCC(F)(F)/C(=C\\C(=O)N3CCC(N4CCCCC4)CC3)c3ccccc32)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 6 rings containing 3 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1ccc(CCC(Cn2ccnc2)Sc2c(Cl)cccc2Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-HSE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)OCC(=O)[C@@]12OC3(CCCC3)O[C@@H]1C[C@H]1[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity polycyclic system with 6 rings. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cn1cnc([N+](=O)[O-])c1Sc1ncnc2nc[nH]c12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 3 aromatic ring(s). HIGH-RISK FEATURES: nitro group (potential mutagenicity). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CO[C@@]1(NC(=O)CSCC#N)C(=O)N2C(C(=O)O)=C(CSc3nnnn3C)CS[C@@H]21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly hydrophilic polycyclic system with 3 rings containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(c1ccccc1)c1ccc2n1CC[C@H]2C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C1c2c(Cl)ccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@H]12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 4 rings containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CO[C@@]1(NC(=O)C(C(=O)O)c2ccc(O)cc2)C(=O)N2C(C(=O)O)=C(CSc3nnnn3C)CO[C@@H]21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 5 rings containing 3 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC[N+]1(CC)CCC(=C(c2ccccc2)c2ccccc2)C1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc(B(c2ccccc2)c2ccccc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR, NR-ER, NR-ER-LBD) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1CCCCCCCCCCCN1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity monocyclic system. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 5 rings containing 4 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) and cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[n+]1c2cc(N)ccc2cc2ccc(N)cc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR, NR-Aromatase) and cellular stress response (SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. The presence of these structural features suggests potential for nuclear receptor activation (NR-AR) and cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(C=Cc1ccccc1)OCCCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CO/N=C(\\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(C[n+]3cccc4c3CCC4)CS[C@H]12)c1csc(N)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic polycyclic system with 5 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)C1=NOC(c2ccccc2)(c2ccccc2)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1CCCC(C)N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1cccc(Cl)c1N=C1NCCN1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccccc1/N=N/c1ccc(/N=N/c2c(O)ccc3ccccc23)c(C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic polycyclic system with 4 rings containing 4 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)[C@]1(c2ccccc2)Oc2ccccc2[C@@H]1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-Aromatase).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(C)Oc2ccc(C#N)cc2[C@@H](N2CCCC2=O)[C@@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)CC1CCCCN1CC(=O)N1c2ccccc2C(=O)Nc2cccnc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC[C@H](NC(C)C)[C@H](O)c1ccc(O)c2[nH]c(=O)ccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C/C(=C(/CCO)SSCC1CCCO1)N(C=O)Cc1cnc(C)nc1N for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)C(C)Oc1ccc(Oc2cnc3cc(Cl)ccc3n2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) and cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1ccccc1-c1nnc(-c2ccccc2Cl)nn1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-ATAD5) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc(N=NNc2ccccc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCC(CC)CN1CN(CC(CC)CCCC)CC(C)(N)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic monocyclic system. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)C1C(=O)C=C(C)OC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OC(CCN1CCCCC1)(c1ccccc1)C1CC2C=CC1C2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN1CCN(c2cc(-c3ccc(F)cc3)c3c(n2)CCCCCC3)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1ccn(C2CO[C@H](CO)O2)c(=O)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C(COCC1CO1)OCC1CO1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic bicyclic framework. HIGH-RISK FEATURES: epoxide ring (DNA alkylation risk). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule N=C1NC(=N)c2ccccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 1 aromatic ring(s). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR-LBD) and cellular stress response (SR-ARE, SR-ATAD5, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(c1ccco1)N1CCNCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OC[C@H]1O[C@@H]2O[C@H]3[C@H](O)[C@@H](O)[C@@H](O[C@H]4[C@H](O)[C@@H](O)[C@@H](O[C@H]5[C@H](O)[C@@H](O)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@@H](O[C@H]7[C@H](O)[C@@H](O)[C@@H](O[C@H]1[C@H](O)[C@H]2O)O[C@@H]7CO)O[C@@H]6CO)O[C@@H]5CO)O[C@@H]4CO)O[C@@H]3CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic polycyclic system with 22 rings. The presence of these structural features suggests potential for nuclear receptor activation (NR-ER) and cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(S(=O)(=O)NC(=O)NN2CCCCCC2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1C(=O)CN2CCc3ccccc3C2c2cc(Cl)ccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) and cellular stress response (SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Brc1c(NC2=NCCN2)ccc2nccnc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CS(=O)(=O)c1ccc(C2=C(c3ccccc3)C(=O)OC2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@H](CN1CCOCC1)C(C(=O)N1CCCC1)(c1ccccc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings containing 2 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-PPAR-gamma) and cellular stress response (SR-ARE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=c1[nH][nH]c2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 2 aromatic ring(s). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1C(=O)c2cccc3cccc1c23 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR) and cellular stress response (SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C1CCC2=NCCCN2CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule N#CC(CCc1ccc(Cl)cc1)(Cn1cncn1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-Aromatase).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@@H]1CCC[C@H](C)N1CCCC(O)(c1ccccc1)c1ccccn1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1CCN(CCCC(=O)c2ccc(F)cc2)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(Nc1ccccc1SSc1ccccc1NC(=O)c1ccccc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic polycyclic system with 4 rings containing 4 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR, NR-ER, NR-PPAR-gamma) and cellular stress response (SR-HSE, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCCCc1cc(O)c2c(c1)OC(C)(C)c1ccc(C)cc1-2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) and cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C(=O)C(Cl)Cl)c1ccc(OC(=O)c2ccco2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCNC1(c2cccs2)CCCCC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=c1sc2ccccc2c(O)c1C1CC(c2ccc(-c3ccc(Br)cc3)cc2)Cc2ccccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 6 rings containing 5 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE, SR-HSE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccccc1N1CCN(CCCC(=O)c2ccc(F)cc2)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(C[C@H](N)C(=O)N[C@H]2[C@@H](O)[C@H](n3cnc4c(N(C)C)ncnc43)O[C@@H]2CO)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly hydrophilic polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit cellular stress response (SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(NCCC(c1ccccc1)c1ccccc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCC(=O)N1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(N)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic polycyclic system with 3 rings containing 1 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C[N+]1(CC2COC(c3ccccc3)(C3CCCCC3)O2)CCCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 4 rings containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)Oc2c(C)c(C)c3c(c2C)CC[C@@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)O3)C(C)(C)CCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 3 rings containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-Aromatase) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=S1(=O)CC=CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc([C@H]2Oc3cc([C@H]4Oc5cc(O)cc(O)c5C(=O)[C@@H]4O)ccc3O[C@@H]2CO)ccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 5 rings containing 3 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) and cellular stress response (SR-HSE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCn1nc(C(=O)O)c(=O)c2cc3c(cc21)OCO3 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 2 aromatic ring(s). SAFETY FEATURES: carboxylic acid (promotes excretion). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CCCOc2ccc(F)cc2)CC1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(N[C@H]1CN2CCC1CC2)c1ccc2c(c1)OCCO2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 5 rings containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(OCCCCCOC(=O)c1ccccc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule OC[C@H]1O[C@@H]2O[C@H]3[C@H](O)[C@@H](O)[C@@H](O[C@H]4[C@H](O)[C@@H](O)[C@@H](O[C@H]5[C@H](O)[C@@H](O)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@@H](O[C@H]7[C@H](O)[C@@H](O)[C@@H](O[C@H]8[C@H](O)[C@@H](O)[C@@H](O[C@H]9[C@H](O)[C@@H](O)[C@@H](O[C@H]1[C@H](O)[C@H]2O)O[C@@H]9CO)O[C@@H]8CO)O[C@@H]7CO)O[C@@H]6CO)O[C@@H]5CO)O[C@@H]4CO)O[C@@H]3CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic polycyclic system with 30 rings. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc(CN(Cc2ccccc2)Cc2ccccc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)C1CSSSC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. The presence of these structural features suggests potential for cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(C=C2CCCC(=Cc3ccc(O)c(OC)c3)C2=O)ccc1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit cellular stress response (SR-ARE, SR-HSE, SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(C(=O)N2CCN(CC(=O)N3CCOCC3)CC2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1nc(N)c(-c2ccccc2)s1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)c1ccc([C@H]2CC[C@H](NC[C@H](O)COc3ccc(O)c(NS(C)(=O)=O)c3)CC2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCOc1sc(C(=O)N2CCC(c3cc(CN)ccc3F)CC2)c(C)c1Br for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AR-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1ccc2c(c1)nc(C(=O)NC1CCN(C3CC3)CC1)n2Cc1cc(-c2ccc(Cl)s2)on1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic polycyclic system with 6 rings containing 4 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COCCOc1cc2cc(C(=O)NC3CCN(C(C)C)CC3)n(CC(=O)Nc3ccc(Cl)cn3)c2cn1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)NC1(c2cccc(F)c2)CCN(CC[C@@]2(c3ccc(Cl)c(Cl)c3)CN(c3ccccc3)C(=O)CO2)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic polycyclic system with 5 rings containing 3 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule S=C1SCN(Cc2ccccc2)CN1Cc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER, NR-PPAR-gamma) and cellular stress response (SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)COc1cc(-c2nn(C)c(OC(F)F)c2Cl)c(F)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 5 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(OCC1CO1)C1CCCCC1C(=O)OCC1CO1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings. HIGH-RISK FEATURES: epoxide ring (DNA alkylation risk). SAFETY FEATURES: ester (metabolic deactivation pathway). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE, SR-ATAD5, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 4 rings containing 3 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(-c2ccc(=O)[nH]n2)ccc1OC(F)F for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ATAD5).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)c1ccccc1C(=O)Nc1cccc2ccccc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(OCc1ccccc1)C(=O)OCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccccc1CO[C@H]1C[C@]2(C(C)C)CC[C@@]1(C)O2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1c2oc3c(C)ccc(C(=O)N[C@@H]4C(=O)N[C@H](C(C)C)C(=O)N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)c3nc-2c(C(=O)N[C@@H]2C(=O)N[C@H](C(C)C)C(=O)N3CCC[C@H]3C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]2C)c(N)c1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, moderately polar polycyclic system with 7 rings containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). these structural features indicate this compound may exhibit nuclear receptor activation (NR-Aromatase) and cellular stress response (SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN1CC(CCN2CCOCC2)C(c2ccccc2)(c2ccccc2)C1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings containing 2 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with cellular stress response (SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(CCCN1CCN(c2ccc(F)cc2)CC1)NC1c2ccccc2CSc2ccccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 5 rings containing 3 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOC(=O)Cn1cccc1-c1nc(-c2ccc(OC)cc2)c(-c2ccc(OC)cc2)s1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 4 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc(CNCC(O)COc2ccc3[nH]c(=O)ccc3c2)cc1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(=O)CC(=O)Nc1ccc2[nH]c(=O)[nH]c2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccccc1N1CCN(CCc2nnc3n2CCCC3)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. these structural features indicate this compound may exhibit nuclear receptor activation (NR-ER, NR-ER-LBD) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C1CCC2(CCCCO2)OC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity bicyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=S(=O)(O)c1ccc2c(/N=N\\c3ccc(S(=O)(=O)O)c4ccccc34)c(O)c(S(=O)(=O)O)cc2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity polycyclic system with 4 rings containing 4 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCc1cc(C2=C(C(=O)O)N(c3ccccc3C(F)(F)F)S(=O)(=O)c3ccccc32)cc2c1OCO2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic polycyclic system with 5 rings containing 3 aromatic ring(s). MODERATE-RISK: 3 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). The presence of these structural features suggests potential for cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc2c3c(c1)C(c1ccccc1)=N[C@@H](NC(=O)c1ccncc1)C(=O)N3CC2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 5 rings containing 3 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for nuclear receptor activation (NR-PPAR-gamma) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)c1cc(/C=C2\\SC(=N)NC2=O)cc(C(C)(C)C)c1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit cellular stress response (SR-ARE, SR-MMP) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1NC(=O)C(=O)C(=O)N1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)OC(=O)c1ncn2c1[C@@H]1CCCN1C(=O)c1c(Br)cccc1-2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1C(=S)CN=C(c2ccccc2)c2cc(Cl)ccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc2c(c1)OCC(CN1CCCCC1)O2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 1 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)CCC(c1ccccc1)c1ccccn1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=P(O)(OCc1ccccc1)OCc1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1CCc2cc(Cl)c(O)cc2[C@H]2c3ccccc3CC[C@@H]21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc(C(=O)NC2CCCNC2)cc(OC)c1OC for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O[C@H]1C[C@H]2CC[C@@H](C1)[N+]21CCCC1)C(O)(c1ccccc1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 5 rings containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc2c3cc1Oc1cc(ccc1O)C[C@@H]1c4c(cc(OC)c(O)c4Oc4ccc(cc4)C[C@@H]3N(C)CC2)CC[N+]1(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 8 rings containing 4 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC1NC(=O)c2cc(S(N)(=O)=O)c(Cl)cc2N1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(/C=C/c2ccc3cc(N(C)C)ccc3[n+]2C)c(C)n1-c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 4 aromatic ring(s). MODERATE-RISK: aniline moiety. Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-MMP, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@@H]1NC(=O)[C@@H](N)CNC(=O)[C@H]([C@@H]2CCNC(N)=N2)NC(=O)/C(=C/NC(N)=O)NC(=O)[C@H](CNC(=O)C[C@@H](N)CCCN)NC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic bicyclic framework. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1cccc2cccnc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER, NR-ER-LBD).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(N)c2cc(NC(=O)Nc3ccc4nc(C)cc(N)c4c3)ccc2n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 4 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CO[C@@H]1[C@@H](OC)[C@H](C)[C@@](O)(CC(=O)O)O[C@H]1[C@H](C)[C@H]1O[C@@]2(CC[C@@](C)([C@H]3CC[C@@](C)([C@@H]4O[C@@H]([C@H]5O[C@](C)(O)[C@H](C)C[C@@H]5C)C[C@@H]4OC4C[C@H](OC)[C@@H](OC)[C@H](C)O4)O3)O2)C[C@H](O)[C@H]1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic polycyclic system with 7 rings. SAFETY FEATURES: carboxylic acid (promotes excretion). these structural features indicate this compound may exhibit cellular stress response (SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)CCc1c[nH]c2ccc(CS(=O)(=O)N3CCCC3)cc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C[C@H]1CN2CC[C@H]1C[C@H]2[C@H](O)c1ccnc2ccc(OC)cc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 5 rings containing 2 aromatic ring(s). The presence of these structural features suggests potential for nuclear receptor activation (NR-AR, NR-AhR, NR-ER) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1nnc2n1-c1sc(CCC(=O)N3CCOCC3)cc1C(c1ccccc1Cl)=NC2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 5 rings containing 3 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1(S(=O)(=O)O)CC(=O)c2ccccc2C1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) and cellular stress response (SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=c1oc2cc(O)ccc2s1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CO/N=C(\\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(CSc3nc(=O)c(O)nn3C)CS[C@H]12)c1csc(N)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC12CCC(CC1)C(C)(C)O2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, balanced lipophilicity polycyclic system with 3 rings. Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc2cc1Oc1cc3c(cc1OC)CC[N+](C)(C)[C@H]3Cc1ccc(cc1)Oc1c(OC)c(OC)cc3c1[C@@H](C2)[N+](C)(C)CC3 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 8 rings containing 4 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)CCCN1c2ccccc2C(C)(C)c2ccccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(OC[C@H]1O[C@@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@@H]1OC(=O)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(O)c2)c1)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(O)c2)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, lipophilic polycyclic system with 11 rings containing 10 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: ester (metabolic deactivation pathway). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AR, NR-AhR) and cellular stress response (SR-ARE, SR-ATAD5, SR-MMP, SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Nc1cnn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. these structural features indicate this compound may exhibit cellular stress response (SR-p53) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(N=Nc2c(O)ccc(N=Nc3ccc(S(=O)(=O)O)cc3)c2O)c(C)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule c1cnc2c(n1)CCCC2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 1 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1CCCC(=O)C1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1OCCC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1occc1SSc1ccoc1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic bicyclic framework containing 2 aromatic ring(s). The presence of these structural features suggests potential for cellular stress response (SR-HSE, SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COP(=O)(OC)SCn1c(=O)oc2cc(Cl)cnc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1cc2c(cc1OC)C1CC(=O)C(CC(C)C)CN1CC2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CNc1cc(OC)c(C(=O)N[C@H]2CCN(Cc3ccccc3)[C@H]2C)cc1Cl for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCO/C=C1\\N=C(c2ccccc2)OC1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule F/C(COc1ccc2c(c1)[nH]c1ccccc12)=C1/CN2CCC1CC2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 6 rings containing 3 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(NC1CCN(CCc2c[nH]c3ccccc23)CC1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings containing 3 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=O)c1cn(Cc2c(F)cccc2F)nn1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)Cc1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion). these structural features indicate this compound may exhibit nuclear receptor activation (NR-PPAR-gamma) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule NC1=NCC2c3ccccc3Cc3ccccc3N12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1nn(CSP(=S)(OC)OC)c(=O)s1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar monocyclic system containing 1 aromatic ring(s). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule S=c1[nH]cnc2[nH]cnc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 2 aromatic ring(s). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR) and cellular stress response (SR-ARE, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1CN1P(=O)(N1CC1C)N1CC1C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C1NCN(c2ccccc2)C12CCN(CCCOc1ccc(F)cc1)CC2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). The presence of these structural features suggests potential for cellular stress response (SR-ARE, SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC1(C)CC(=O)NC(=O)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. SAFETY FEATURES: amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)c1ccc(C)cc1C1=NC(=O)C(C)(C(C)C)N1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway), amide bond (metabolic stability). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=c1oc2cc(O)ccc2c2oc3cc(O)ccc3c12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 4 rings containing 4 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-ATAD5, SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccccc1OCC(O)CNCCOc1ccc(C(N)=O)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 2 aromatic ring(s). SAFETY FEATURES: amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=c1n(CC2CO2)c(=O)n(CC2CO2)c(=O)n1CC1CO1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic polycyclic system with 4 rings containing 1 aromatic ring(s). HIGH-RISK FEATURES: epoxide ring (DNA alkylation risk). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE, SR-ATAD5, SR-HSE, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C=C1C[C@]23CC[C@H]4[C@](C)(CCC[C@@]4(C)C(=O)O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@@H]2C[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@H]2OC2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H]1C3 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic polycyclic system with 8 rings. SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1ccc(C=C2C(=O)C3CCC2C3(C)C)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 1 aromatic ring(s). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=C(C(=O)Nc2ccccc2)SCCO1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-ATAD5).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCC1OCC(COc2ccc(Oc3ccccc3)cc2)O1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). these structural features indicate this compound may exhibit nuclear receptor activation (NR-AhR, NR-ER) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule N#CC1(N=NC2(C#N)CCCCC2)CCCCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CO[C@H]1C[C@H](O[C@H]2[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@H](N(C)C)[C@H]3OC(C)=O)[C@@H](C)C[C@]3(CO3)C(=O)[C@H](C)[C@@H](OC(C)=O)[C@@H](C)[C@@H](C)OC(=O)[C@@H]2C)O[C@@H](C)[C@@H]1OC(C)=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, balanced lipophilicity polycyclic system with 4 rings. HIGH-RISK FEATURES: epoxide ring (DNA alkylation risk). SAFETY FEATURES: ester (metabolic deactivation pathway). Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1C[C@H]2c3ccccc3Oc3ccc(Cl)cc3[C@@H]2C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCn1nc(C)c2c1C(=O)NCC(c1ccc(O)cc1)=N2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1cc(SC2=C(O)C[C@@](CCc3ccc(N)cc3)(C(C)C)OC2=O)c(C(C)(C)C)cc1CO for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cc1nc(C)nc(N2C[C@@H](C)N(c3ccnc([C@@H](C)O)n3)[C@@H](C)C2)n1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(NO)C1(NS(=O)(=O)c2ccc(Oc3ccc(F)cc3)cc2)CCOCC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(O)CCN(C1(C(=O)NO)CCCC1)S(=O)(=O)c1ccc(Oc2ccc(F)cc2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Oc1ccc2c(c1)OC[C@@H](N1CCC(O)(c3ccc(F)cc3)CC1)[C@H]2O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), phenolic group (metabolic activation potential). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR, NR-ER) and cellular stress response (SR-ATAD5) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccc2sc(C(=O)Nc3nnn[nH]3)c(OC(C)C)c2c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-Aromatase, NR-PPAR-gamma).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings containing 4 aromatic ring(s). Structural analysis reveals these structural features that correlate with nuclear receptor activation (NR-AhR) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Clc1cnc(Oc2ccc(Oc3ncc(Cl)cc3Cl)cc2)c(Cl)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly lipophilic polycyclic system with 3 rings containing 3 aromatic ring(s). MODERATE-RISK: 4 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for cellular stress response (SR-MMP) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1CN1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, highly hydrophilic monocyclic system. The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule c1ccc2c(c1)Oc1ccccc1S2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). Based on the scaffold, these structural features are likely drivers for nuclear receptor activation (NR-ER) and cellular stress response (SR-MMP).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C[C@]12CC[C@H]3[C@@H](CC[C@@]45O[C@@H]4C(O)=C(C#N)C[C@]35C)[C@@H]1CC[C@@H]2O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 5 rings. HIGH-RISK FEATURES: epoxide ring (DNA alkylation risk). The presence of these structural features suggests potential for nuclear receptor activation (NR-AR, NR-AR-LBD, NR-ER) and cellular stress response (SR-ARE, SR-p53) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)CCc1c[nH]c2ccc(Cn3cncn3)cc12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 3 rings containing 3 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN1CCN=C(c2ccccc2)c2cc(Cl)ccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation), aniline moiety. Despite its functional groups, the molecule shows no activity in toxicity assays.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)[C@@H]1C(O)=C(C(=O)NCN2CCCC2)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)C3C[C@@H]12 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, moderately polar polycyclic system with 5 rings containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: amide bond (metabolic stability). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1=C(C(=O)Nc2ccccc2)S(=O)(=O)CCO1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE, SR-p53).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CC[C@H]1[C@@H]2C[C@H]3[C@@H]4N(C)c5ccccc5[C@]45C[C@@H](C2[C@H]5O)N3[C@@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 7 rings containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN[C@H]1CN(CCCOC)S(=O)(=O)c2sc(S(N)(=O)=O)cc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, moderately polar bicyclic framework containing 1 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN(CC)CCOC(=O)C(Cc1cccc2ccccc12)CC1CCCO1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC1COC(Cn2cncn2)(c2ccc(Oc3ccc(Cl)cc3)cc2Cl)O1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 4 rings containing 3 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). Structural analysis reveals these structural features that correlate with cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule C/C(=N\\NC(=O)Nc1cc(F)cc(F)c1)c1ncccc1C(=O)O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation), aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN(C)CCn1nnnc1SCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)Cc3csc(N)n3)[C@H]2SC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: carboxylic acid (promotes excretion), amide bond (metabolic stability). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(C=Cc1ccc(O)c(O)c1)O[C@@H]1C[C@](O)(C(=O)O)C[C@@H](O)[C@H]1O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, highly hydrophilic bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential). SAFETY FEATURES: carboxylic acid (promotes excretion), ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCNC(=O)N1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). SAFETY FEATURES: amide bond (metabolic stability). these structural features indicate this compound may exhibit cellular stress response (SR-ARE) in biological systems.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, balanced lipophilicity polycyclic system with 4 rings containing 2 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CC(C)(C)[C@]1(O)CCN2C[C@H]3c4ccccc4CCc4cccc(c43)[C@@H]2C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a large, complex, lipophilic polycyclic system with 5 rings containing 2 aromatic ring(s). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCN1CCc2nc(N)oc2CC1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar bicyclic framework containing 1 aromatic ring(s). MODERATE-RISK: aniline moiety. Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CCCC(CCC)C(=O)O[C@H]1C[C@H]2CC[C@@H](C1)[N+]2(C)C for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, balanced lipophilicity bicyclic framework. SAFETY FEATURES: ester (metabolic deactivation pathway). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule COC(=O)C1=CCCN(C)C1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a small, fragment-like, moderately polar monocyclic system. SAFETY FEATURES: ester (metabolic deactivation pathway). The compound contains its functional groups but lacks the specific reactivity needed for toxic responses.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule Cn1c(=O)c2c(ncn2CC2OCCO2)n(C)c1=O for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, highly hydrophilic polycyclic system with 3 rings containing 2 aromatic ring(s). Although its functional groups are present, the molecule appears benign across the screened pathways.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule O=C(Nc1ccc2c(O)c(N=Nc3ccc(N=Nc4ccc(S(=O)(=O)O)cc4)cc3)c(S(=O)(=O)O)cc2c1)c1ccccc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 5 rings containing 5 aromatic ring(s). MODERATE-RISK: phenolic group (metabolic activation potential), aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Based on the scaffold, these structural features are likely drivers for cellular stress response (SR-ARE).\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule CCOc1ccc(N=Nc2ccc(C=Cc3ccc(N=Nc4ccc(OCC)cc4)cc3S(=O)(=O)O)c(S(=O)(=O)O)c2)cc1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly lipophilic polycyclic system with 4 rings containing 4 aromatic ring(s). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  },
  {
    "instruction": "Analyze the molecule CN[C@@H]1C[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, lipophilic polycyclic system with 3 rings containing 2 aromatic ring(s). MODERATE-RISK: 2 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for nuclear receptor activation (NR-AhR) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule Cl/C=C\\C[N+]12CN3CN(CN(C3)C1)C2 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a medium-sized, drug-like, moderately polar polycyclic system with 4 rings. MODERATE-RISK: 1 halogen atom(s) (potential bioaccumulation). The presence of these structural features suggests potential for cellular stress response (SR-ARE) based on established toxicophores.\n</think>\n\nPrediction: Toxic"
  },
  {
    "instruction": "Analyze the molecule NC(=O)c1ccc[n+]([C@@H]2O[C@H](COP(=O)([O-])OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(N)ncnc54)[C@H](O)[C@@H]3O)[C@@H](O)[C@H]2O)c1 for toxicity.",
    "input": "",
    "output": "<think>\nThis is a very large, macromolecular, highly hydrophilic polycyclic system with 5 rings containing 3 aromatic ring(s). MODERATE-RISK: aniline moiety. SAFETY FEATURES: amide bond (metabolic stability). Structural elements like its functional groups do not translate to measurable toxicity in screening.\n</think>\n\nPrediction: Non-Toxic"
  }
]